AI Dynamics

Global AI News Aggregator

About

Biomarkers as Health Proxies in Clinical Trial Design

The way they try to do that is by using known biomarkers as a proxy for health. Then you can setup trials to monitor the effect of treatment/drug/habbit by looking at those markers. It's scientific within the assumption that the markers are connected to life expentency.

→ View original post on X — @alexjc